Enterosgel in Guidelines for Treatment and Prevention of COVID-19

In 2020, Enterosgel (active ingredient – polymethylsiloxane polyhydrate) has been included into the following guidelines:

• Interim Guidelines: Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection (COVID-19) – for pathogenetic treatment in cases of severe intoxication, abdominal pain, nausea and/or vomiting.
• Guidelines. Medical Care For Pregnant Patients, Women In Labour, Puerperas, and Newborns With the Novel Coronavirus Infection Covid-19.
• Diagnosis, Treatment And Prevention Of The Novel Coronavirus Infection (Covid-19): Guidelines for the Medical Personnel of the Armed Forces of the Russian Federation.
• Interim Guidelines: Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection (COVID-19)  in the Kyrgyz Republic.
  
   
  
   

Exhibitor Data Sheet